These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

986 related articles for article (PubMed ID: 23324188)

  • 61. Fertility-preserving surgery for advanced stage ovarian germ cell tumors.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
    Gynecol Oncol; 2017 Dec; 147(3):493-496. PubMed ID: 29021083
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.
    Chan JK; Zhang M; Kaleb V; Loizzi V; Benjamin J; Vasilev S; Osann K; Disaia PJ
    Gynecol Oncol; 2005 Jan; 96(1):204-9. PubMed ID: 15589602
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2015 Jun; 137(3):418-22. PubMed ID: 25842162
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.
    Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F
    J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Long-term outcome and analysis of prognostic factors in 114 cases of postoperative stage III gastric cancer].
    Zhang Y; Ma LW
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):863-6. PubMed ID: 24447487
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours.
    Gadducci A; Lanfredini N; Tana R
    Gynecol Endocrinol; 2014 Jul; 30(7):467-71. PubMed ID: 24702194
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Progress in survival outcomes in patients with advanced ovarian cancer treated by neo-adjuvant platinum/taxane-based chemotherapy and late interval debulking surgery.
    Stoeckle E; Bourdarias L; Guyon F; Croce S; Brouste V; Thomas L; Floquet A
    Ann Surg Oncol; 2014 Feb; 21(2):629-36. PubMed ID: 24052318
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.
    Fizazi K; Tjulandin S; Salvioni R; Germà-Lluch JR; Bouzy J; Ragan D; Bokemeyer C; Gerl A; Fléchon A; de Bono JS; Stenning S; Horwich A; Pont J; Albers P; De Giorgi U; Bower M; Bulanov A; Pizzocaro G; Aparicio J; Nichols CR; Théodore C; Hartmann JT; Schmoll HJ; Kaye SB; Culine S; Droz JP; Mahé C
    J Clin Oncol; 2001 May; 19(10):2647-57. PubMed ID: 11352956
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary.
    Talukdar S; Kumar S; Bhatla N; Mathur S; Thulkar S; Kumar L
    Gynecol Oncol; 2014 Jan; 132(1):28-32. PubMed ID: 24145115
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
    Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
    Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Possibility of women treated with fertility-sparing surgery for non-epithelial ovarian tumors to safely and successfully become pregnant-a Chinese retrospective cohort study among 148 cases.
    Yang B; Yu Y; Chen J; Zhang Y; Yin Y; Yu N; Chen G; Zhu S; Huang H; Yuan Y; Ai J; Wang X; Li K
    Front Med; 2018 Oct; 12(5):509-517. PubMed ID: 29218679
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma - analysis of patient data in the prospective OVCAD study.
    Hofstetter G; Concin N; Braicu I; Chekerov R; Sehouli J; Cadron I; Van Gorp T; Trillsch F; Mahner S; Ulmer H; Grimm C; Castillo-Tong DC; Zeillinger R; Zeimet AG; Vergote I
    Gynecol Oncol; 2013 Oct; 131(1):15-20. PubMed ID: 23877013
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Jun; 145(3):513-518. PubMed ID: 28372870
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Impact of Surgical Staging on the Prognosis of Mucinous Borderline Tumors of the Ovaries: A Multicenter Study.
    Gungorduk K; Asicioglu O; Braicu EI; Almuheimid J; Gokulu SG; Cetinkaya N; Gungor T; Pakay G; Telli EU; Cuylan ZF; Toptas T; Bilgi A; Ozyurt R; Agacayak E; Ozdemir A; Yildirim N; Taskin S; Oge T; Erol O; Akman L; Turan A; Icen MS; Senol T; Ovali OI; Yucesoy B; Gungorduk O; Temizkan O; Sanci M; Simsek T; Meydanli MM; Harma M; Yasar L; Uysal AD; Karateke A; Ortac F; Ozalp SS; Sehouli J; Muallem MZ
    Anticancer Res; 2017 Oct; 37(10):5609-5616. PubMed ID: 28982877
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
    Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
    BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival.
    Kadera BE; Sunjaya DB; Isacoff WH; Li L; Hines OJ; Tomlinson JS; Dawson DW; Rochefort MM; Donald GW; Clerkin BM; Reber HA; Donahue TR
    JAMA Surg; 2014 Feb; 149(2):145-53. PubMed ID: 24306217
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
    Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study.
    Kajiyama H; Mizuno M; Shibata K; Yamamoto E; Kawai M; Nagasaka T; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():97-102. PubMed ID: 24507757
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognosis for advanced-stage primary peritoneal serous papillary carcinoma and serous ovarian cancer in Taiwan.
    Chao KC; Chen YJ; Juang CM; Lau HY; Wen KC; Sung PL; Fang FY; Twu NF; Yen MS
    Taiwan J Obstet Gynecol; 2013 Mar; 52(1):81-4. PubMed ID: 23548224
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Positive peritoneal cytology at interval surgery is a poor prognostic factor in patients with stage T3c advanced ovarian carcinoma: A retrospective study.
    Nagasaka K; Kawana K; Tomio K; Tsuruga T; Mori-Uchino M; Miura S; Tanikawa M; Miyamoto Y; Ikeda Y; Sone K; Adachi K; Matsumoto Y; Arimoto T; Oda K; Osuga Y; Fujii T
    J Obstet Gynaecol Res; 2015 May; 41(5):755-62. PubMed ID: 25421004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.